RT Book, Section
A1 Friedman, David
A1 Gillaim, Frank G.
A2 Duchowny, Michael
A2 Cross, J. Helen
A2 Arzimanoglou, Alexis
SR Print(0)
ID 1138411914
T1 Impact of Comorbidities on Health Outcomes
T2 Pediatric Epilepsy
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071496216
LK neurology.mhmedical.com/content.aspx?aid=1138411914
RD 2024/04/18
AB The  World  Health  Organization  defines  health  as  "a  state  of  complete  physical,  mental,  and  social  well-being  and  not  merely  the  absence  of  disease  or  infirmity."1  In  the  past,  measures  of  success  in  treating  medical  illness  have  been  thought  of  in  terms  of  freedom  of  disease  or  identifiable  quantifiable  endpoints,  such  as  serum  glucose,  systolic  blood  pressure,  or  seizures.2  However,  recently,  there  has  been  an  emergence  of  interest  in  measuring  health-related  quality  of  life  (HRQOL),  a  valid  and  significant  indicator  of  health  in  patients  with  disease.  This  idea  has  been  studied  over  the  past  decade  and  applied  to  develop  reliable  and  valid  measures  of  function  and  well-being  for  use  in  patients  with  epilepsy.3  This  concept  especially  pertains  to  chronic  epilepsy,  where  though  many  treating  clinicians  focus  on  treating  the  ictal  phenomenon  of  the  disease,  namely  seizures,  the  disease  itself  carries  a  multitude  of  clinically  relevant  interictal  comorbidities  that  affects  patients'  overall  HRQOL.